Benefits
Bone mineral density support
Population studies consistently show positive associations between dietary silicon intake and bone mineral density in both pre- and postmenopausal women and men. A 2-year RCT with ch-OSA® showed significant improvements in bone collagen markers (CICP) and a trend toward improved bone mineral density — suggesting silicon supports the collagen matrix component of bone rather than just mineral density.
Collagen synthesis stimulation
Orthosilicic acid stimulates collagen type 1 synthesis in osteoblasts, fibroblasts, and chondrocytes — the structural protein scaffold upon which bone mineral is deposited. Prolyl hydroxylase (the collagen-crosslinking enzyme) requires silicon for optimal activity, providing a mechanistic explanation for silicon's bone and connective tissue effects.
Skin, hair, and nail quality improvement
ch-OSA® RCTs in women with photoaged skin showed significant improvements in skin microrelief, skin elasticity, and hair tensile strength after 20 weeks — attributed to increased dermal collagen synthesis. Silicon's role in cross-linking structural proteins (collagen, elastin, glycosaminoglycans) explains its cosmetic skin and hair applications.
Aluminum detoxification
Orthosilicic acid forms stable, non-absorbable aluminosilicate complexes in the GI tract and may reduce aluminum absorption from diet and water. Population studies suggest silicon-rich drinking water reduces Alzheimer's disease risk — potentially through aluminum-silicate formation preventing aluminum's neurotoxic accumulation.
Mechanism of action
Prolyl hydroxylase activation and collagen crosslinking
Orthosilicic acid appears to stabilize prolyl hydroxylase — the enzyme that hydroxylates proline residues in procollagen, enabling hydroxyproline formation essential for collagen triple helix stability and crosslinking. Silicon may also interact directly with the hydroxyl groups of collagen and glycosaminoglycans, stabilizing the extracellular matrix structure.
Osteoblast collagen gene expression upregulation
OSA at physiological concentrations stimulates osteoblasts to increase expression of collagen type 1 alpha-1 (COL1A1) and osteocalcin genes, and activates osteoblast differentiation markers. This direct osteoblast stimulation explains silicon's effects on the organic (protein) component of bone matrix — complementary to calcium's effects on the inorganic mineral component.
Aluminosilicate formation and neuroprotection
Silicon and aluminum form insoluble aluminosilicate complexes at physiological pH. In the GI tract, dietary silicon reduces aluminum absorption by forming these complexes before intestinal absorption can occur. Systemically, silicon may facilitate urinary aluminum excretion, potentially protecting neural tissue from aluminum-mediated toxicity.
Clinical trials
Randomized, double-blind, placebo-controlled trial of ch-OSA® (10 mg/day bioavailable silicon) vs. placebo combined with calcium + vitamin D3 in 136 osteopenic women for 12 months.
136 osteopenic women. 12-month intervention.
ch-OSA® significantly improved CICP (bone collagen synthesis marker) by 22% vs. placebo + calcium/D3. Trend toward improved femoral neck BMD. Supports silicon as bone collagen-targeting supplement complementary to calcium.
Randomized, double-blind, placebo-controlled trial of ch-OSA® (10 mg/day silicon) in 50 women with photoaged skin for 20 weeks.
50 women with photoaged facial skin. 20-week cosmetic study.
ch-OSA® significantly improved skin microrelief score, skin roughness, and skin elasticity vs. placebo. Hair tensile strength significantly improved. Nail brittleness reduced. Confirms silicon's structural role in connective tissue cosmetic outcomes.